• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构性心脏病患者消融后快速非临床室性心动过速的诱导:定义和临床意义。

Fast nonclinical ventricular tachycardia inducible after ablation in patients with structural heart disease: Definition and clinical implications.

机构信息

Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.

Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

Heart Rhythm. 2018 May;15(5):668-676. doi: 10.1016/j.hrthm.2018.01.013. Epub 2018 Jan 8.

DOI:10.1016/j.hrthm.2018.01.013
PMID:29325974
Abstract

BACKGROUND

Noninducibility of ventricular tachycardia (VT) with an equal or longer cycle length (CL) than that of the clinical VT is considered the minimum ablation endpoint in patients with structural heart disease. Because their clinical relevance remains unclear, fast nonclinical VTs are often not targeted. However, an accepted definition for fast VT is lacking. The shortest possible CL of a monomorphic reentrant VT is determined by the ventricular refractory period (VRP).

OBJECTIVE

The purpose of this study was to propose a patient-specific definition for fast VT based on the individual VRP (fVT) and assess the prognostic significance of persistent inducibility after ablation of fVT for VT recurrence.

METHODS

Of 191 patients with previous myocardial infarction or with nonischemic cardiomyopathy undergoing VT ablation, 70 (age 63 ± 13 years; 64% ischemic) remained inducible for a nonclinical VT and composed the study population. FVT was defined as any VT with CL ≤VRP + 30 ms. Patients were followed for VT recurrence.

RESULTS

After ablation, 30 patients (43%) remained inducible exclusively for fVT and 40 (57%) for any slower VT. Patients with only fVT had 3-year VT-free survival of 64% (95% confidence interval [CI] 46%-82%) compared to 27% (95% CI 14%-48%) for patients with any slower remaining VT (P = .013). Inducibility of only fVT was independently associated with lower VT recurrence (hazard ratio 0.38; 95% CI 0.19-0.86; P = .019). Among 36 patients inducible for any fVT, only 1 had recurrence with fVT.

CONCLUSION

In patients with structural heart disease, inducibility of exclusively fVT after ablation is associated with low VT recurrence.

摘要

背景

在结构性心脏病患者中,诱发与临床室性心动过速(VT)等长或更长周期(CL)的 VT 不能诱导是消融的最低终点。由于其临床相关性尚不清楚,快速非临床性 VT 通常不是治疗靶点。然而,缺乏公认的快速 VT 定义。单相折返性 VT 的最短 CL 由心室不应期(VRP)决定。

目的

本研究旨在提出一种基于个体 VRP(fVT)的快速 VT 患者特异性定义,并评估消融 fVT 后持续性可诱导性对 VT 复发的预测意义。

方法

在 191 例既往心肌梗死或非缺血性心肌病患者中,70 例(年龄 63±13 岁;64%为缺血性)行 VT 消融术,仍可诱发出非临床性 VT,作为研究人群。fVT 定义为 CL≤VRP+30ms 的任何 VT。患者接受 VT 复发随访。

结果

消融后,30 例(43%)患者仅对 fVT 具有可诱导性,40 例(57%)患者对任何较慢的 VT 具有可诱导性。仅 fVT 可诱导患者 3 年 VT 无复发生存率为 64%(95%置信区间 [CI] 46%-82%),而任何较慢的剩余 VT 患者为 27%(95% CI 14%-48%)(P=0.013)。仅 fVT 的可诱导性与较低的 VT 复发相关(风险比 0.38;95% CI 0.19-0.86;P=0.019)。在 36 例可诱发出任何 fVT 的患者中,仅有 1 例因 fVT 复发。

结论

在结构性心脏病患者中,消融后仅 fVT 可诱导与 VT 复发率低相关。

相似文献

1
Fast nonclinical ventricular tachycardia inducible after ablation in patients with structural heart disease: Definition and clinical implications.结构性心脏病患者消融后快速非临床室性心动过速的诱导:定义和临床意义。
Heart Rhythm. 2018 May;15(5):668-676. doi: 10.1016/j.hrthm.2018.01.013. Epub 2018 Jan 8.
2
Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.非缺血性心肌病患者室性心动过速消融的结果:可诱发性的影响。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):513-21. doi: 10.1161/CIRCEP.113.000089. Epub 2013 Apr 25.
3
Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.心脏结节病继发难治性室性心动过速:电生理特征、标测与消融
Heart Rhythm. 2006 Aug;3(8):924-9. doi: 10.1016/j.hrthm.2006.03.031. Epub 2006 Mar 30.
4
Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.导管消融术后无复发性室性心动过速与结构性心脏病患者生存率提高相关:一项国际室性心动过速消融中心协作组研究。
Heart Rhythm. 2015 Sep;12(9):1997-2007. doi: 10.1016/j.hrthm.2015.05.036. Epub 2015 May 30.
5
Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.有结构性心脏病和无结构性心脏病患者行室性心动过速导管消融术后的长期预后
Heart Rhythm. 2016 Oct;13(10):1957-63. doi: 10.1016/j.hrthm.2016.07.001. Epub 2016 Jul 5.
6
Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality?非缺血性扩张型心肌病患者室性心动过速的导管消融与死亡率:消融后不能诱发是否可作为死亡率降低的预测指标?
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):598-605. doi: 10.1161/CIRCEP.114.002295. Epub 2015 Apr 14.
7
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.缺血性心肌病中稳定型室性心动过速的消融与基质消融的比较:VISTA 随机多中心试验。
J Am Coll Cardiol. 2015 Dec 29;66(25):2872-2882. doi: 10.1016/j.jacc.2015.10.026.
8
Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.在窦性心律下使用电解剖标测进行基质改良以治疗缺血性心肌病患者的室性心动过速。
Z Kardiol. 2005 Jul;94(7):453-60. doi: 10.1007/s00392-005-0240-3.
9
Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.非缺血性心肌病患者室性心动过速消融后的长期预后:晚电位消除和 VT 不能诱导。
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008307. doi: 10.1161/CIRCEP.119.008307. Epub 2020 Jul 12.
10
Multicenter Experience With Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy.多中心经导管消融治疗 lamin A/C 心肌病所致室性心动过速的临床经验。
Circ Arrhythm Electrophysiol. 2016 Aug;9(8). doi: 10.1161/CIRCEP.116.004357.

引用本文的文献

1
Evoked delayed potential ablation for post-myocardial infarction ventricular tachycardia: results from a large prospective multicentre study.心肌梗死后室性心动过速的诱发延迟电位消融:一项大型前瞻性多中心研究的结果
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf003.
2
Pre-ablation and Post-ablation Factors Influencing the Prognosis of Patients with Electrical Storm Treated by Radiofrequency Catheter Ablation: An Update.影响射频导管消融治疗电风暴患者预后的消融前及消融后因素:最新进展
Rev Cardiovasc Med. 2024 Dec 5;25(12):432. doi: 10.31083/j.rcm2512432. eCollection 2024 Dec.
3
Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society.
立体定向心律失常射频消融的患者选择、室性心动过速基质描绘及数据传输:欧洲心脏病学会欧洲心律协会和心律协会的临床共识声明
Europace. 2025 Mar 28;27(4). doi: 10.1093/europace/euae214.
4
Efficacy and safety of catheter ablation as first-line therapy for the management of ventricular tachycardia.导管消融作为一线治疗管理室性心动过速的疗效和安全性。
J Interv Card Electrophysiol. 2023 Oct;66(7):1701-1711. doi: 10.1007/s10840-023-01483-2. Epub 2023 Feb 9.
5
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常。
J Interv Card Electrophysiol. 2020 Oct;59(1):145-298. doi: 10.1007/s10840-019-00663-3.
6
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常
Heart Rhythm. 2020 Jan;17(1):e2-e154. doi: 10.1016/j.hrthm.2019.03.002. Epub 2019 May 10.
7
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常。
Europace. 2019 Aug 1;21(8):1143-1144. doi: 10.1093/europace/euz132.